Literature DB >> 29268486

Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle.

Giuseppe Gargiulo1,2, Marco Valgimigli1.   

Abstract

Year:  2017        PMID： 29268486      PMCID： PMC5721050          DOI： 10.21037/jtd.2017.10.28

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  27 in total

1.  New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?

Authors:  Giuseppe Gargiulo; Davide Capodanno; Anna Sannino; Marco Barbanti; Cinzia Perrino; Piera Capranzano; Eugenio Stabile; Ciro Indolfi; Bruno Trimarco; Corrado Tamburino; Giovanni Esposito
Journal:  Int J Cardiol       Date:  2015-10-19       Impact factor: 4.164

2.  A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?

Authors:  Giuseppe Gargiulo; Stephan Windecker; Pascal Vranckx; Charles Michael Gibson; Roxana Mehran; Marco Valgimigli
Journal:  Circulation       Date:  2016-12-06       Impact factor: 29.690

3.  Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.

Authors:  George D Dangas; Thierry Lefèvre; Christian Kupatt; Didier Tchetche; Ulrich Schäfer; Nicolas Dumonteil; John G Webb; Antonio Colombo; Stephan Windecker; Jurriën M Ten Berg; David Hildick-Smith; Roxana Mehran; Peter Boekstegers; Axel Linke; Christophe Tron; Eric Van Belle; Anita W Asgar; Andreas Fach; Raban Jeger; Gennaro Sardella; Hans Ulrich Hink; Oliver Husser; Eberhard Grube; Efthymios N Deliargyris; Ilknur Lechthaler; Debra Bernstein; Peter Wijngaard; Prodromos Anthopoulos; Christian Hengstenberg
Journal:  J Am Coll Cardiol       Date:  2015-10-15       Impact factor: 24.094

4.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

Authors:  Alain Cribier; Helene Eltchaninoff; Assaf Bash; Nicolas Borenstein; Christophe Tron; Fabrice Bauer; Genevieve Derumeaux; Frederic Anselme; François Laborde; Martin B Leon
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

5.  Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.

Authors:  Stephan Windecker; Jan Tijssen; Gennaro Giustino; Ana H C Guimarães; Roxana Mehran; Marco Valgimigli; Pascal Vranckx; Robert C Welsh; Usman Baber; Gerrit-Anne van Es; Peter Wildgoose; Albert A Volkl; Ana Zazula; Karen Thomitzek; Melanie Hemmrich; George D Dangas
Journal:  Am Heart J       Date:  2016-10-31       Impact factor: 4.749

6.  Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.

Authors:  Josep Rodés-Cabau; Jean-Bernard Masson; Robert C Welsh; Bruno Garcia Del Blanco; Marc Pelletier; John G Webb; Faisal Al-Qoofi; Philippe Généreux; Gabriel Maluenda; Martin Thoenes; Jean-Michel Paradis; Chekrallah Chamandi; Vicenç Serra; Eric Dumont; Mélanie Côté
Journal:  JACC Cardiovasc Interv       Date:  2017-05-17       Impact factor: 11.195

7.  A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation.

Authors:  Anna Sannino; Giuseppe Gargiulo; Gabriele Giacomo Schiattarella; Cinzia Perrino; Eugenio Stabile; Maria-Angela Losi; Maurizio Galderisi; Raffaele Izzo; Giovanni de Simone; Bruno Trimarco; Giovanni Esposito
Journal:  EuroIntervention       Date:  2016-10-10       Impact factor: 6.534

8.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

9.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

10.  Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.

Authors:  Marco Valgimigli; Francesco Costa; Yuliya Lokhnygina; Robert M Clare; Lars Wallentin; David J Moliterno; Paul W Armstrong; Harvey D White; Claes Held; Philip E Aylward; Frans Van de Werf; Robert A Harrington; Kenneth W Mahaffey; Pierluigi Tricoci
Journal:  Eur Heart J       Date:  2017-03-14       Impact factor: 29.983
View more
  1 in total

1.  Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Authors:  Davide Capodanno; Marco Di Maio; Antonio Greco; Deepak L Bhatt; C Michael Gibson; Andreas Goette; Renato D Lopes; Roxana Mehran; Pascal Vranckx; Dominick J Angiolillo
Journal:  J Am Heart Assoc       Date:  2020-08-01       Impact factor: 5.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.